Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 26;S1551-7411(20)30284-9.
doi: 10.1016/j.sapharm.2020.03.012. Online ahead of print.

Recommendations and Guidance for Providing Pharmaceutical Care Services During COVID-19 Pandemic: A China Perspective

Affiliations
Free PMC article
Review

Recommendations and Guidance for Providing Pharmaceutical Care Services During COVID-19 Pandemic: A China Perspective

Si-Qian Zheng et al. Res Social Adm Pharm. .
Free PMC article

Abstract

Background: The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic.

Objective: To discuss community pharmacists' role and the content of pharmaceutical care (PC) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population.

Method: Collect and summarize the experience Chinese community pharmacies gained from providing pharmacy services during the COVID-19 outbreak, and taking patients' PC needs into consideration, analyze and discuss the methods and strategies that community pharmacies and pharmacists shall use to provide PC during the pandemic.

Results: Community pharmacy management teams shall support PC services by providing adequate supply of COVID-19 related medications and preventative products, following environment regulations, and providing sufficient staff trainings. Pharmacists shall use various approaches to provide PC services in drug dispensing, consulting and referrals, chronic disease management, safe use of infusions, patient education, home care guidance and psychological support to promote the COVID-19 pandemic control and ensure safe medication use of community patients during the pandemic.

Conclusion: PC services in communities during the COVID-19 shall possess different properties due to disease characteristics and related change in patients' need. Community pharmacies shall work as a strong supporter of patient's medication and protective equipment supply. Community pharmacists shall be prepared to provide skilled and effective PC services for community patient population to ensure medication safety and promote the overall COVID-19 pandemic control.

Keywords: COVID-19; Community pharmacy; Novel coronavirus pneumonia; Pharmaceutical care; Safe medication use.

Conflict of interest statement

Declaration of competing interest To the best of our knowledge, the named authors have no conflict of interest, financial or otherwise, of the submitted work.

Figures

Fig. 1
Fig. 1
An overview of the recommended content of community pharmaceutical care services during the COVID-19 outbreak.

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Chinese Pharmaceutical Association CORONAVIRUS SARS-CoV-2 INFECTION: Expert Consensus on guidance and prevention strategies for hospital pharmacists and the pharmacy workforce (2nd edition) [EB/OL]. [2020-03-03] http://www.cpa.org.cn/cpadmn/attached/file/20200216/1581854567839722.pdf
    1. International Pharmaceutical Federation CORONAVIRUS SARS-CoV-2 OUTBREAK: information and interim guidelines for pharmacists and the pharmacy workforce [EB/OL]. [2020-03-03] https://www.fip.org/file/4428
    1. National Health Commission of the People’s Republic of China Diagnosis and treatment plan for patients with novel coronavirus pneumonia (6th trial version) [EB/OL]. [2020-02-20] http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf
    1. Wei M., Chen Q., Yu D.M. The development of pharmaceutical care in domestic and foreign communities and its enlightenment on establishing pharmacy major in China [J] Chin Pharmaceut J. 2010;(12):98–100.
    1. Centers for Disease Control and Prevention Evaluating and reporting persons under investigation (PUI) [EB/OL]. [2020-03-04] https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html

LinkOut - more resources

Feedback